US Stock MarketDetailed Quotes

FTRE Fortrea Holdings

Watchlist
  • 10.960
  • +0.580+5.59%
Close Mar 4 16:00 ET
  • 8.500
  • -2.460-22.45%
Pre 04:20 ET
988.59MMarket Cap-2.99P/E (TTM)

About Fortrea Holdings Company

Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. It operates under the Clinical Services and Enabling Services Segments. The Clinical Services segment provides services across the clinical pharmacology, clinical development, and other clinical service spectrum utilizing enabling services and technology through multiple delivery models. The Enabling Services segment provides technology solutions directly to customers that streamline complex randomization and optimize the trial drug supply process, while minimizing operational costs and supporting timely and accurate patient dosing. The company was founded on January 31, 2023 and is headquartered in Durham, NC.

Company Profile

SymbolFTRE
Company NameFortrea Holdings
Listing DateJun 16, 2023
Founded2023
CEOMr. Thomas H. Pike
MarketNASDAQ
Employees15500
Fiscal Year Ends12-31
Address8 Moore Drive
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27709
Phone1-877-495-0816

Company Executives

  • Name
  • Position
  • Salary
  • Thomas H. Pike
  • Chairman of the Board, President and Chief Executive Officer
  • 26.32M
  • Jill McConnell
  • Chief Financial Officer
  • 3.08M
  • Mark A. Morais
  • Chief Operating Officer and President, Clinical Services
  • 3.23M
  • Robert A. Parks
  • Chief Accounting Officer
  • --
  • Machelle Sanders
  • Director
  • --
  • Dr. Amrit Ray, M.D.
  • Independent Director
  • --
  • David R. Smith
  • Independent Director
  • --
  • Edward A. Pesicka
  • Independent Director
  • --
  • Erin L. Russell
  • Independent Director
  • --
  • Peter M. Neupert
  • Lead Independent Director
  • --

Trending Stocks

Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More